SCHEMBL177426

SCHEMBL177426

CN(C)CCC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL7172121 0.97
Hydrochloric Acid SCHEMBL958972 0.97
Hydrochloric Acid SCHEMBL3484568 0.97 GSR (0.37)
Hydrochloric Acid SCHEMBL3855667 0.97 GSR (0.37)
SCHEMBL9680430 0.97
Oxalic Acid SCHEMBL5863163 0.92 ALDH1A1 (0.35)
SCHEMBL7131637 0.88 GSR (0.42)
SCHEMBL177924 0.86
Methacrylic Acid SCHEMBL27670122 0.84 TDP1 (0.39)
Trifluoroacetic Acid SCHEMBL5369290 0.84 HTR5A (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1920 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250368650-A1 5-(4-FLUOROPHENYL)-2,3-DIHYDRO-1H-IMIDAZO[1,2-A]IMIDAZOLE DERIVATIVES AS ALK INHIBITORS FOR THE TREATMENT OF FIBROSIS CHIESI FARMACEUTICI S.P.A. (IT) 2025-12-04 US claimed
EP-4619099-A1 PYRIDO OXAZOLIDINONE DERIVATIVES AS ALK5 INHIBITORS Chiesi Farmaceutici S.p.A. (IT) 2025-09-24 EP claimed
US-20250145578-A1 SMALL MOLECULES TARGETTING EIF3E TO INHIBIT TUMOR GROWTH PROGRESSION, AND METASTASIS THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE 2025-05-08 US claimed
US-20250144226-A1 METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE Design Therapeutics, Inc. 2025-05-08 US claimed
CN-116289310-B Safe low-chlorine paper cationic rosin size for food contact and preparation method thereof 南昌市龙然实业有限公司 2024-07-26 CN claimed
CN-118307947-A Polycarbonate composite material and application thereof 天津金发新材料有限公司 2024-07-09 CN claimed
CN-115335369-B GEM-disubstituted piperidine melanocortin subtype-2 receptor (MC 2R) antagonists and uses thereof 克林提克斯医药股份有限公司 2024-07-02 CN claimed
CN-118165490-A PC/PMMA alloy material and application thereof 金发科技股份有限公司 2024-06-11 CN claimed
WO-2024105070-A1 PYRIDO OXAZOLIDINONE DERIVATIVES AS ALK5 INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2024-05-23 WO claimed
WO-2023158866-A2 SMALL MOLECULES TARGETTING EIF3E TO INHIBIT TUMOR GROWTH PROGRESSION, AND METASTASIS THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2023-08-24 WO claimed
EP-0162034-A2 Method of isolating monoclonal antibodies from hybridoma cultures MONSANTO COMPANY (US) 1985-11-21 EP claimed
US-4533496-A CONTACTING COLTURE MEDIUM WITH WATER-INSOLUBLE CROSSLINKED POLYELECTROLYTE COPOLYMER MONSANTO COMPANY (US) 1985-08-06 US claimed
US-4471112-A ETHYLENE-MALEIC ANHYDRIDE COPOLYMERS CROSSLINKED WITH AMINE COMPOUNDS MONSANTO COMPANY (US) 1984-09-11 US claimed
EP-0099871-A1 Separation of plasma proteins from cell culture systems Monsanto Company (US) 1984-02-01 EP claimed
EP-0098256-A2 Production of blood coagulation factor VIII:C MONSANTO COMPANY (US) 1984-01-11 EP claimed
US-4397841-A ADSORPTION ON CROSS-LINKED POLYELECTROLYTE MONSANTO COMPANY (US) 1983-08-09 US claimed
US-4382028-A CROSSLINKED POLYELECTROLYTE MONSANTO COMPANY (US) 1983-05-03 US claimed
US-4157431-A Separation of blood coagulation factors with non-activating polyelectrolytes MONSANTO COMPANY (US) 1979-06-05 US claimed
US-4122265-A APPETITE SUPPRESSANTS HOFFMANN-LA ROCHE INC. (US) 1978-10-24 US claimed
US-4007121-A ETHYLENE-PROPYLENE TEXACO INC. (US) 1977-02-08 US claimed